Dermal Fillers: US Market Assessment
A Survey of Fifty-One Dermatologists and Plastic Surgeons
Deliverable: PowerPoint presentation with key findings.
Study Description
|
Topic |
Dermal Fillers |
|
Respondent Type |
Physicians |
|
Specialties Covered |
Dermatology & Plastic Surgery |
|
Region |
United States Only |
|
Methodology |
Online survey, self-administered via a Panel Intelligence website § A 10-minute self-administered survey was § Fielded from February 9th – February 13th, 2007. |
Objectives
To evaluate the competitive landscape of the dermal fillers market.
§ Understand current perceptions and usage patterns of dermal fillers.
§ Determine the market potential of Juvederm within the dermal fillers market.
§ Assess current use of laser treatment procedures.
§ Gauge perceptions and market potential of novel dermal fillers.
Companies and Products Mentioned in This Report
|
Company |
Ticker Symbol |
Product(s) |
|
Allergan |
AGN |
Botox® Cosmetic (botulinum toxin type A) Juvederm™ |
|
Mentor |
MNT |
Puretox® (botulinum toxin type A) |
|
Medicis |
MRX |
Restylane® Reloxin® / Dysport® (botulinum toxin type A) |
Inclusion Criteria and Respondent Demographics
|
Inclusion Criteria
|
§ Have been in practice between 2 and 30 years § Spend at least 75% of their professional time in clinical practice § Treat at least 15 patients per month using collagen/hyaluronic acid dermal fillers § Treat at least 15 patients per month using BOTOX cosmetic treatment |
| © Panel Intelligence, LLC. 1999-2008. All rights reserved. A wholly owned subsidiary of MCF Corporation (NASDAQ: MERR) Privacy Policy |